img

Global Sepsis Diagnostics Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Sepsis Diagnostics Market Research Report 2024

Sepsis is a three-staged syndrome; it starts with systemic infections leading to severe sepsis and ultimately causing sepsis shock, which is regarded as a medical emergency. Population with weak immune system, which include children, older adults, and people with chronic diseases such as cancer, AIDS, diabetes, are prone to sepsis.
Sepsis occurs mainly due to bacterial, viral, and fungal infections. Gram-negative bacilli such as E. coli, P. aeruginosa, E. corrodens, and Haemophilus influenzae (which occurs mainly in neonates) are the main agents that cause infection, leading to sepsis. Other bacteria which causes sepsis are S. aureus, Streptococcus species, Enterococcus species, and Neisseria species.
According to MRAResearch’s new survey, global Sepsis Diagnostics market is projected to reach US$ 528.8 million in 2033, increasing from US$ 360.5 million in 2022, with the CAGR of 5.2% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Sepsis Diagnostics market research.
North America is expected to command the largest share of the market in 2018, due to the growing prevalence of sepsis, fast adoption of high-end sepsis diagnostics devices, and rising government support for sepsis-related research.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Sepsis Diagnostics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Biomerieux
T2 Biosystems
Luminex
Becton, Dickinson
Roche
Danaher
Thermo Fisher
Bruker
Abbott
Immunexpress
Response Biomedical
Axis-Shield Diagnostics
Cytosorbents
Mitsubishi Chemical
EKF Diagnostics
Segment by Type
Microbiology
Molecular Diagnostics
Immunoassays
Flow Cytometry
Microfluidics
Biomarkers

Segment by Application


Hospitals
Pathology & Reference Laboratories
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Sepsis Diagnostics report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sepsis Diagnostics Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Microbiology
1.2.3 Molecular Diagnostics
1.2.4 Immunoassays
1.2.5 Flow Cytometry
1.2.6 Microfluidics
1.2.7 Biomarkers
1.3 Market by Application
1.3.1 Global Sepsis Diagnostics Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Pathology & Reference Laboratories
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Sepsis Diagnostics Market Perspective (2018-2033)
2.2 Sepsis Diagnostics Growth Trends by Region
2.2.1 Global Sepsis Diagnostics Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Sepsis Diagnostics Historic Market Size by Region (2018-2023)
2.2.3 Sepsis Diagnostics Forecasted Market Size by Region (2024-2033)
2.3 Sepsis Diagnostics Market Dynamics
2.3.1 Sepsis Diagnostics Industry Trends
2.3.2 Sepsis Diagnostics Market Drivers
2.3.3 Sepsis Diagnostics Market Challenges
2.3.4 Sepsis Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Sepsis Diagnostics Players by Revenue
3.1.1 Global Top Sepsis Diagnostics Players by Revenue (2018-2023)
3.1.2 Global Sepsis Diagnostics Revenue Market Share by Players (2018-2023)
3.2 Global Sepsis Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Sepsis Diagnostics Revenue
3.4 Global Sepsis Diagnostics Market Concentration Ratio
3.4.1 Global Sepsis Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sepsis Diagnostics Revenue in 2022
3.5 Sepsis Diagnostics Key Players Head office and Area Served
3.6 Key Players Sepsis Diagnostics Product Solution and Service
3.7 Date of Enter into Sepsis Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Sepsis Diagnostics Breakdown Data by Type
4.1 Global Sepsis Diagnostics Historic Market Size by Type (2018-2023)
4.2 Global Sepsis Diagnostics Forecasted Market Size by Type (2024-2033)
5 Sepsis Diagnostics Breakdown Data by Application
5.1 Global Sepsis Diagnostics Historic Market Size by Application (2018-2023)
5.2 Global Sepsis Diagnostics Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Sepsis Diagnostics Market Size (2018-2033)
6.2 North America Sepsis Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Sepsis Diagnostics Market Size by Country (2018-2023)
6.4 North America Sepsis Diagnostics Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Sepsis Diagnostics Market Size (2018-2033)
7.2 Europe Sepsis Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Sepsis Diagnostics Market Size by Country (2018-2023)
7.4 Europe Sepsis Diagnostics Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Sepsis Diagnostics Market Size (2018-2033)
8.2 Asia-Pacific Sepsis Diagnostics Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Sepsis Diagnostics Market Size by Region (2018-2023)
8.4 Asia-Pacific Sepsis Diagnostics Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Sepsis Diagnostics Market Size (2018-2033)
9.2 Latin America Sepsis Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Sepsis Diagnostics Market Size by Country (2018-2023)
9.4 Latin America Sepsis Diagnostics Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Sepsis Diagnostics Market Size (2018-2033)
10.2 Middle East & Africa Sepsis Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Sepsis Diagnostics Market Size by Country (2018-2023)
10.4 Middle East & Africa Sepsis Diagnostics Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Biomerieux
11.1.1 Biomerieux Company Detail
11.1.2 Biomerieux Business Overview
11.1.3 Biomerieux Sepsis Diagnostics Introduction
11.1.4 Biomerieux Revenue in Sepsis Diagnostics Business (2018-2023)
11.1.5 Biomerieux Recent Development
11.2 T2 Biosystems
11.2.1 T2 Biosystems Company Detail
11.2.2 T2 Biosystems Business Overview
11.2.3 T2 Biosystems Sepsis Diagnostics Introduction
11.2.4 T2 Biosystems Revenue in Sepsis Diagnostics Business (2018-2023)
11.2.5 T2 Biosystems Recent Development
11.3 Luminex
11.3.1 Luminex Company Detail
11.3.2 Luminex Business Overview
11.3.3 Luminex Sepsis Diagnostics Introduction
11.3.4 Luminex Revenue in Sepsis Diagnostics Business (2018-2023)
11.3.5 Luminex Recent Development
11.4 Becton, Dickinson
11.4.1 Becton, Dickinson Company Detail
11.4.2 Becton, Dickinson Business Overview
11.4.3 Becton, Dickinson Sepsis Diagnostics Introduction
11.4.4 Becton, Dickinson Revenue in Sepsis Diagnostics Business (2018-2023)
11.4.5 Becton, Dickinson Recent Development
11.5 Roche
11.5.1 Roche Company Detail
11.5.2 Roche Business Overview
11.5.3 Roche Sepsis Diagnostics Introduction
11.5.4 Roche Revenue in Sepsis Diagnostics Business (2018-2023)
11.5.5 Roche Recent Development
11.6 Danaher
11.6.1 Danaher Company Detail
11.6.2 Danaher Business Overview
11.6.3 Danaher Sepsis Diagnostics Introduction
11.6.4 Danaher Revenue in Sepsis Diagnostics Business (2018-2023)
11.6.5 Danaher Recent Development
11.7 Thermo Fisher
11.7.1 Thermo Fisher Company Detail
11.7.2 Thermo Fisher Business Overview
11.7.3 Thermo Fisher Sepsis Diagnostics Introduction
11.7.4 Thermo Fisher Revenue in Sepsis Diagnostics Business (2018-2023)
11.7.5 Thermo Fisher Recent Development
11.8 Bruker
11.8.1 Bruker Company Detail
11.8.2 Bruker Business Overview
11.8.3 Bruker Sepsis Diagnostics Introduction
11.8.4 Bruker Revenue in Sepsis Diagnostics Business (2018-2023)
11.8.5 Bruker Recent Development
11.9 Abbott
11.9.1 Abbott Company Detail
11.9.2 Abbott Business Overview
11.9.3 Abbott Sepsis Diagnostics Introduction
11.9.4 Abbott Revenue in Sepsis Diagnostics Business (2018-2023)
11.9.5 Abbott Recent Development
11.10 Immunexpress
11.10.1 Immunexpress Company Detail
11.10.2 Immunexpress Business Overview
11.10.3 Immunexpress Sepsis Diagnostics Introduction
11.10.4 Immunexpress Revenue in Sepsis Diagnostics Business (2018-2023)
11.10.5 Immunexpress Recent Development
11.11 Response Biomedical
11.11.1 Response Biomedical Company Detail
11.11.2 Response Biomedical Business Overview
11.11.3 Response Biomedical Sepsis Diagnostics Introduction
11.11.4 Response Biomedical Revenue in Sepsis Diagnostics Business (2018-2023)
11.11.5 Response Biomedical Recent Development
11.12 Axis-Shield Diagnostics
11.12.1 Axis-Shield Diagnostics Company Detail
11.12.2 Axis-Shield Diagnostics Business Overview
11.12.3 Axis-Shield Diagnostics Sepsis Diagnostics Introduction
11.12.4 Axis-Shield Diagnostics Revenue in Sepsis Diagnostics Business (2018-2023)
11.12.5 Axis-Shield Diagnostics Recent Development
11.13 Cytosorbents
11.13.1 Cytosorbents Company Detail
11.13.2 Cytosorbents Business Overview
11.13.3 Cytosorbents Sepsis Diagnostics Introduction
11.13.4 Cytosorbents Revenue in Sepsis Diagnostics Business (2018-2023)
11.13.5 Cytosorbents Recent Development
11.14 Mitsubishi Chemical
11.14.1 Mitsubishi Chemical Company Detail
11.14.2 Mitsubishi Chemical Business Overview
11.14.3 Mitsubishi Chemical Sepsis Diagnostics Introduction
11.14.4 Mitsubishi Chemical Revenue in Sepsis Diagnostics Business (2018-2023)
11.14.5 Mitsubishi Chemical Recent Development
11.15 EKF Diagnostics
11.15.1 EKF Diagnostics Company Detail
11.15.2 EKF Diagnostics Business Overview
11.15.3 EKF Diagnostics Sepsis Diagnostics Introduction
11.15.4 EKF Diagnostics Revenue in Sepsis Diagnostics Business (2018-2023)
11.15.5 EKF Diagnostics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Sepsis Diagnostics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Microbiology
Table 3. Key Players of Molecular Diagnostics
Table 4. Key Players of Immunoassays
Table 5. Key Players of Flow Cytometry
Table 6. Key Players of Microfluidics
Table 7. Key Players of Biomarkers
Table 8. Global Sepsis Diagnostics Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 9. Global Sepsis Diagnostics Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 10. Global Sepsis Diagnostics Market Size by Region (2018-2023) & (US$ Million)
Table 11. Global Sepsis Diagnostics Market Share by Region (2018-2023)
Table 12. Global Sepsis Diagnostics Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 13. Global Sepsis Diagnostics Market Share by Region (2024-2033)
Table 14. Sepsis Diagnostics Market Trends
Table 15. Sepsis Diagnostics Market Drivers
Table 16. Sepsis Diagnostics Market Challenges
Table 17. Sepsis Diagnostics Market Restraints
Table 18. Global Sepsis Diagnostics Revenue by Players (2018-2023) & (US$ Million)
Table 19. Global Sepsis Diagnostics Market Share by Players (2018-2023)
Table 20. Global Top Sepsis Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sepsis Diagnostics as of 2022)
Table 21. Ranking of Global Top Sepsis Diagnostics Companies by Revenue (US$ Million) in 2022
Table 22. Global 5 Largest Players Market Share by Sepsis Diagnostics Revenue (CR5 and HHI) & (2018-2023)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Sepsis Diagnostics Product Solution and Service
Table 25. Date of Enter into Sepsis Diagnostics Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Sepsis Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 28. Global Sepsis Diagnostics Revenue Market Share by Type (2018-2023)
Table 29. Global Sepsis Diagnostics Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 30. Global Sepsis Diagnostics Revenue Market Share by Type (2024-2033)
Table 31. Global Sepsis Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 32. Global Sepsis Diagnostics Revenue Market Share by Application (2018-2023)
Table 33. Global Sepsis Diagnostics Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 34. Global Sepsis Diagnostics Revenue Market Share by Application (2024-2033)
Table 35. North America Sepsis Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. North America Sepsis Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Sepsis Diagnostics Market Size by Country (2024-2033) & (US$ Million)
Table 38. Europe Sepsis Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 39. Europe Sepsis Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 40. Europe Sepsis Diagnostics Market Size by Country (2024-2033) & (US$ Million)
Table 41. Asia-Pacific Sepsis Diagnostics Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 42. Asia-Pacific Sepsis Diagnostics Market Size by Region (2018-2023) & (US$ Million)
Table 43. Asia-Pacific Sepsis Diagnostics Market Size by Region (2024-2033) & (US$ Million)
Table 44. Latin America Sepsis Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Latin America Sepsis Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 46. Latin America Sepsis Diagnostics Market Size by Country (2024-2033) & (US$ Million)
Table 47. Middle East & Africa Sepsis Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 48. Middle East & Africa Sepsis Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Sepsis Diagnostics Market Size by Country (2024-2033) & (US$ Million)
Table 50. Biomerieux Company Detail
Table 51. Biomerieux Business Overview
Table 52. Biomerieux Sepsis Diagnostics Product
Table 53. Biomerieux Revenue in Sepsis Diagnostics Business (2018-2023) & (US$ Million)
Table 54. Biomerieux Recent Development
Table 55. T2 Biosystems Company Detail
Table 56. T2 Biosystems Business Overview
Table 57. T2 Biosystems Sepsis Diagnostics Product
Table 58. T2 Biosystems Revenue in Sepsis Diagnostics Business (2018-2023) & (US$ Million)
Table 59. T2 Biosystems Recent Development
Table 60. Luminex Company Detail
Table 61. Luminex Business Overview
Table 62. Luminex Sepsis Diagnostics Product
Table 63. Luminex Revenue in Sepsis Diagnostics Business (2018-2023) & (US$ Million)
Table 64. Luminex Recent Development
Table 65. Becton, Dickinson Company Detail
Table 66. Becton, Dickinson Business Overview
Table 67. Becton, Dickinson Sepsis Diagnostics Product
Table 68. Becton, Dickinson Revenue in Sepsis Diagnostics Business (2018-2023) & (US$ Million)
Table 69. Becton, Dickinson Recent Development
Table 70. Roche Company Detail
Table 71. Roche Business Overview
Table 72. Roche Sepsis Diagnostics Product
Table 73. Roche Revenue in Sepsis Diagnostics Business (2018-2023) & (US$ Million)
Table 74. Roche Recent Development
Table 75. Danaher Company Detail
Table 76. Danaher Business Overview
Table 77. Danaher Sepsis Diagnostics Product
Table 78. Danaher Revenue in Sepsis Diagnostics Business (2018-2023) & (US$ Million)
Table 79. Danaher Recent Development
Table 80. Thermo Fisher Company Detail
Table 81. Thermo Fisher Business Overview
Table 82. Thermo Fisher Sepsis Diagnostics Product
Table 83. Thermo Fisher Revenue in Sepsis Diagnostics Business (2018-2023) & (US$ Million)
Table 84. Thermo Fisher Recent Development
Table 85. Bruker Company Detail
Table 86. Bruker Business Overview
Table 87. Bruker Sepsis Diagnostics Product
Table 88. Bruker Revenue in Sepsis Diagnostics Business (2018-2023) & (US$ Million)
Table 89. Bruker Recent Development
Table 90. Abbott Company Detail
Table 91. Abbott Business Overview
Table 92. Abbott Sepsis Diagnostics Product
Table 93. Abbott Revenue in Sepsis Diagnostics Business (2018-2023) & (US$ Million)
Table 94. Abbott Recent Development
Table 95. Immunexpress Company Detail
Table 96. Immunexpress Business Overview
Table 97. Immunexpress Sepsis Diagnostics Product
Table 98. Immunexpress Revenue in Sepsis Diagnostics Business (2018-2023) & (US$ Million)
Table 99. Immunexpress Recent Development
Table 100. Response Biomedical Company Detail
Table 101. Response Biomedical Business Overview
Table 102. Response Biomedical Sepsis Diagnostics Product
Table 103. Response Biomedical Revenue in Sepsis Diagnostics Business (2018-2023) & (US$ Million)
Table 104. Response Biomedical Recent Development
Table 105. Axis-Shield Diagnostics Company Detail
Table 106. Axis-Shield Diagnostics Business Overview
Table 107. Axis-Shield Diagnostics Sepsis Diagnostics Product
Table 108. Axis-Shield Diagnostics Revenue in Sepsis Diagnostics Business (2018-2023) & (US$ Million)
Table 109. Axis-Shield Diagnostics Recent Development
Table 110. Cytosorbents Company Detail
Table 111. Cytosorbents Business Overview
Table 112. Cytosorbents Sepsis Diagnostics Product
Table 113. Cytosorbents Revenue in Sepsis Diagnostics Business (2018-2023) & (US$ Million)
Table 114. Cytosorbents Recent Development
Table 115. Mitsubishi Chemical Company Detail
Table 116. Mitsubishi Chemical Business Overview
Table 117. Mitsubishi Chemical Sepsis Diagnostics Product
Table 118. Mitsubishi Chemical Revenue in Sepsis Diagnostics Business (2018-2023) & (US$ Million)
Table 119. Mitsubishi Chemical Recent Development
Table 120. EKF Diagnostics Company Detail
Table 121. EKF Diagnostics Business Overview
Table 122. EKF Diagnostics Sepsis Diagnostics Product
Table 123. EKF Diagnostics Revenue in Sepsis Diagnostics Business (2018-2023) & (US$ Million)
Table 124. EKF Diagnostics Recent Development
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Sepsis Diagnostics Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Sepsis Diagnostics Market Share by Type: 2022 VS 2033
Figure 3. Microbiology Features
Figure 4. Molecular Diagnostics Features
Figure 5. Immunoassays Features
Figure 6. Flow Cytometry Features
Figure 7. Microfluidics Features
Figure 8. Biomarkers Features
Figure 9. Global Sepsis Diagnostics Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 10. Global Sepsis Diagnostics Market Share by Application: 2022 VS 2033
Figure 11. Hospitals Case Studies
Figure 12. Pathology & Reference Laboratories Case Studies
Figure 13. Sepsis Diagnostics Report Years Considered
Figure 14. Global Sepsis Diagnostics Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 15. Global Sepsis Diagnostics Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 16. Global Sepsis Diagnostics Market Share by Region: 2022 VS 2033
Figure 17. Global Sepsis Diagnostics Market Share by Players in 2022
Figure 18. Global Top Sepsis Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sepsis Diagnostics as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Sepsis Diagnostics Revenue in 2022
Figure 20. North America Sepsis Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. North America Sepsis Diagnostics Market Share by Country (2018-2033)
Figure 22. United States Sepsis Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Canada Sepsis Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Sepsis Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Europe Sepsis Diagnostics Market Share by Country (2018-2033)
Figure 26. Germany Sepsis Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. France Sepsis Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. U.K. Sepsis Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Italy Sepsis Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Russia Sepsis Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Nordic Countries Sepsis Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific Sepsis Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Asia-Pacific Sepsis Diagnostics Market Share by Region (2018-2033)
Figure 34. China Sepsis Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Japan Sepsis Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. South Korea Sepsis Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Southeast Asia Sepsis Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. India Sepsis Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Australia Sepsis Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America Sepsis Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Latin America Sepsis Diagnostics Market Share by Country (2018-2033)
Figure 42. Mexico Sepsis Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Brazil Sepsis Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa Sepsis Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Middle East & Africa Sepsis Diagnostics Market Share by Country (2018-2033)
Figure 46. Turkey Sepsis Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Saudi Arabia Sepsis Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Biomerieux Revenue Growth Rate in Sepsis Diagnostics Business (2018-2023)
Figure 49. T2 Biosystems Revenue Growth Rate in Sepsis Diagnostics Business (2018-2023)
Figure 50. Luminex Revenue Growth Rate in Sepsis Diagnostics Business (2018-2023)
Figure 51. Becton, Dickinson Revenue Growth Rate in Sepsis Diagnostics Business (2018-2023)
Figure 52. Roche Revenue Growth Rate in Sepsis Diagnostics Business (2018-2023)
Figure 53. Danaher Revenue Growth Rate in Sepsis Diagnostics Business (2018-2023)
Figure 54. Thermo Fisher Revenue Growth Rate in Sepsis Diagnostics Business (2018-2023)
Figure 55. Bruker Revenue Growth Rate in Sepsis Diagnostics Business (2018-2023)
Figure 56. Abbott Revenue Growth Rate in Sepsis Diagnostics Business (2018-2023)
Figure 57. Immunexpress Revenue Growth Rate in Sepsis Diagnostics Business (2018-2023)
Figure 58. Response Biomedical Revenue Growth Rate in Sepsis Diagnostics Business (2018-2023)
Figure 59. Axis-Shield Diagnostics Revenue Growth Rate in Sepsis Diagnostics Business (2018-2023)
Figure 60. Cytosorbents Revenue Growth Rate in Sepsis Diagnostics Business (2018-2023)
Figure 61. Mitsubishi Chemical Revenue Growth Rate in Sepsis Diagnostics Business (2018-2023)
Figure 62. EKF Diagnostics Revenue Growth Rate in Sepsis Diagnostics Business (2018-2023)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed